Pancreas cancer screening for high-risk individuals
Part of Cancer clinical trials.
This study offers regular pancreas screening (like imaging or blood tests) to people who have a higher risk of developing pancreatic cancer. It aims to catch any early signs of cancer in those with certain family histories, genetic mutations, or other risk factors, potentially leading to earlier treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a close family member with pancreatic cancer, or carry a genetic change (called a pathogenic variant) that raises your risk.
- You may qualify if you have a type of pancreas cyst called an IPMN (a common, often benign finding).
- You may also qualify if you have recently been diagnosed with diabetes (new onset diabetes).
- You need to be able to understand and agree to the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to screen the pancreas in people who are at increased risk for pancreatic cancer, using a set of risk guidelines. Screening may help find cancer (or early changes) sooner, when it may be easier to treat.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This study checks people who are at higher risk for pancreatic cancer using an ultrasound camera passed into the digestive tract (endoscopic ultrasound, EUS), then tracks their results over time. It may help catch early signs and better understand how screening works for high-risk groups.
This Phase 3 study tests a structured plan for checking the pancreas early in people with a higher-than-usual risk of pancreatic cancer. The goal is to find changes sooner, when treatment may be easier.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
Hear when a new Pancreas Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.